Exosome RNA Exosome RNA Research & Industry News
Extracellular vesicles and exosomes are being explored for skin and hair treatments, but concerns remain about product quality, long-term safety, and lack of FDA approval...
Read More »The hidden risks of exosome treatments
Xtressé™ Announces FDA IND Acceptance for Xvie, The First & Only Extracellular Vesicle Injectable Therapy for Androgenetic Alopecia
Xvie advances into simultaneous Phase I/II trials, paving the way for a new category in hair restoration. Xtressé™, the advanced hair health company founded by dermatologists and scientists...
Read More »EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
EVerZom raised €10 million to launch its first clinical trial of EVerGel in 2026, advancing exosome-based regenerative therapies and scaling its GMP...
Read More »World’s First HLA-G Targeted Exosome Therapy for Cancer Enters U.S. Clinical Trials
SOB100, the world’s first HLA-G targeted exosome therapy, uses extracellular vesicles to deliver drugs precisely to tumor cells, offering new hope for...
Read More »Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids
Researchers at ETH Zurich provide a comprehensive review of extracellular vesicles and lipid nanoparticles as nucleic acid delivery systems, highlighting their biogenesis, structural properties, challenges in drug formulation, biodistribution...
Read More »INOVIQ establishes medical and scientific advisory board
INOVIQ Limited announced the establishment of its Medical and Scientific Advisory Board (MSAB). The MSAB will provide world-class research expertise, clinical insight and strategic advice focusing on...
Read More »Plasma extracellular vesicles may be a diagnostic biomarker for FTD-ALS
A study published in Nature Medicine finds that a type of particle associated with specific cell subtypes could potentially be utilized as a biomarker for FTD...
Read More »Why plant-derived exosomes offer a more sustainable and ethical alternative in medical research
As the search for effective, minimally invasive treatments in hair regrowth and skin rejuvenation intensifies, exosomes—small extracellular vesicles...
Read More »A new horizon in drug delivery
An August 2024 publication by Assistant Professor of Health and Exercise Science, Dan Lark, showcases an innovative drug delivery approach for cancer and metabolic diseases, such as Type 2 diabetes and obesity. The approach relies on tiny particles...
Read More »EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors
EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields...
Read More »